Published in TB and Outbreaks Week, November 19th, 2002
After 6 months, the proportion of patients recurrence-free was 80% in those receiving Valtrex 500 mg twice daily, compared to only 38% of those receiving placebo.
"Many people who are HIV-positive also suffer from genital herpes and will be pleased to know they can suppress their genital herpes outbreaks," said Timothy Schacker, MD, associate professor of medicine, University of Minnesota. "This is important information...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week